KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Bristol Myers Squibb (BMY) over the last 17 years, with Q2 2025 value amounting to $2.9 billion.

  • Bristol Myers Squibb's Shares Outstanding changed 0.0% to $2.9 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.9 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.9 billion for FY2024, which is 0.0% changed from last year.
  • Per Bristol Myers Squibb's latest filing, its Shares Outstanding stood at $2.9 billion for Q2 2025, which was down 0.0% from $2.9 billion recorded in Q1 2025.
  • Over the past 5 years, Bristol Myers Squibb's Shares Outstanding peaked at $2.9 billion during Q1 2021, and registered a low of $2.9 billion during Q1 2021.
  • Its 5-year average for Shares Outstanding is $2.9 billion, with a median of $2.9 billion in 2021.
  • Data for Bristol Myers Squibb's Shares Outstanding shows a peak YoY increase of 0.0% (in 2021) and a maximum YoY decrease of 0.0% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Shares Outstanding stood at $2.9 billion in 2021, then changed by 0.0% to $2.9 billion in 2022, then changed by 0.0% to $2.9 billion in 2023, then changed by 0.0% to $2.9 billion in 2024, then changed by 0.0% to $2.9 billion in 2025.
  • Its Shares Outstanding was $2.9 billion in Q2 2025, compared to $2.9 billion in Q1 2025 and $2.9 billion in Q4 2024.